期刊
POSTEPY DERMATOLOGII I ALERGOLOGII
卷 30, 期 5, 页码 293-301出版社
TERMEDIA PUBLISHING HOUSE LTD
DOI: 10.5114/pdia.2013.38358
关键词
antifungal agents; Candida albicans; mode of action; resistance mechanisms
资金
- National Science Centre [DEC-2011/03/D/NZ7/06198]
Recent progress in medical sciences and therapy resulted in an increased number of immunocompromised individuals. Candida albicans is the leading opportunistic fungal pathogen causing infections in humans, ranging from superficial mucosal lesions to disseminated or bloodstream candidiasis. Superficial candidiasis not always presents a risk to the life of the infected host, however it significantly lowers the quality of life. Superficial Candida infections are difficult to treat and their frequency of occurrence is currently rising. To implement successful treatment doctors should be up to date with better understanding of C. albicans resistance mechanisms. Despite high frequency of Candida infections there is a limited number of antimycotics available for therapy. This review focuses on current understanding of the mode of action and resistance mechanisms to conventional and emerging antifungal agents for treatment of superficial and mucosal candidiasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据